Skip to content
Clinical Trials – home
IrelandBack to Ireland

Clinical trials in Drogheda

18 clinical trials in Drogheda, Ireland. Every trial is listed in the EU Clinical Trials Register and updated daily.

Drogheda at a glance
18
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

18 trials in Drogheda

Open in trial search

Asthma

Recruiting

Efficacy and Safety of Depemokimab for Early Intervention in Adults and Adolescents with Type 2 Asthma at Risk of Exacerbations

Registered drug
Countries:IrelandIreland
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Depemokimab
  • Sponsor:Glaxosmithkline Research & Development Limited

Asthma

Recruiting

Efficacy and safety of GB-0895 as adjunctive therapy in adults and adolescents with severe uncontrolled asthma (randomized, placebo‑controlled)

Investigational
Countries:IrelandIreland
  • Participants:0–17 years · 18–64 years · 65+ years
  • Sponsor:Generate Biomedicines Inc.

Study to evaluate the safety and effectiveness of inhaled nintedanib in patients with idiopathic pulmonary fibrosis

Investigational
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Nintedanib
  • Sponsor:Avalyn Pharma Inc.

A Study of Depemokimab Compared to Placebo in Adults with Chronic Obstructive Pulmonary Disease and Type 2 Inflammation

Registered drug
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Depemokimab
  • Sponsor:Glaxosmithkline Research & Development Limited

Hidradenitis

Recruiting

A Study of LAD191 Compared to Placebo and Adalimumab in Adults with Moderate-to-Severe Hidradenitis Suppurativa

Registered drug
Countries:IrelandIreland
  • Participants:18–64 years
  • Substances:Adalimumab
  • Sponsor:Almirall S.A.

Study of MTX-463 compared to placebo to assess its safety and effectiveness in adults with idiopathic pulmonary fibrosis

Registered drug
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Glucose Monohydrate
  • Sponsor:Mediar Therapeutics Inc.

Study on VE303 for Preventing Recurrent C. difficile Infection in Patients

Investigational
Countries:IrelandIreland
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Bacilli, Cluster Xvii, Strain Relative Clostridium_Aq Innocuum, Live
  • Sponsor:Vedanta Biosciences Inc.

Crohn's disease

Recruiting

Study of Lutikizumab, ABBV-382, and Risankizumab for Adults with Moderate to Severe Crohn's Disease

InvestigationalNo placebo
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:ABBV-8736
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

Pulmonary fibrosis

Not yet recruiting

A study to evaluate the effectiveness and safety of admilparant in patients with progressive pulmonary fibrosis

Investigational
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Admilparant
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company

A study to evaluate the effectiveness and safety of admilparant in patients with idiopathic pulmonary fibrosis

Investigational
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Admilparant
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company

Study of Verekitug to improve symptoms in patients with moderate to severe chronic obstructive pulmonary disease (COPD)

Investigational
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Human IgG1 kappa monoclonal antibody against CRLF2
  • Sponsor:Upstream Bio Inc.

Colitis ulcerative

Not recruiting

Comparison of Risankizumab and Vedolizumab for Treatment of Moderate to Severe Ulcerative Colitis in Adults Who Have Not Received Targeted Therapies

Registered drugNo placebo
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Risankizumab
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

Other cities in Ireland

The busiest research cities in the country

All 16 cities in Ireland

Clinical research in Drogheda

What the registry says about research in the country

01 Gastrointestinal Disorders

Innovative research focusing on inflammatory bowel diseases, including trials evaluating new therapeutic approaches for ulcerative colitis and Crohn's disease. Studies are examining novel compounds like obefazimod for improving patient outcomes.

  • Ulcerative Colitis Management
  • Crohn's Disease Treatment
  • Celiac Disease Therapy

Multiple trials are investigating endoscopic improvement and symptomatic remission in patients with moderate to severe conditions.

02 Infectious Disease Prevention

Groundbreaking research in preventing and treating various infections, with particular focus on Clostridioides difficile infection recurrence and surgical site infections following abdominal procedures.

  • Post-Surgical Infection Prevention
  • C. difficile Treatment
  • Anti-infective Therapies

Studies are evaluating novel preventive measures and treatment approaches to reduce infection rates.

03 Dermatological Conditions

Clinical research examining treatments for chronic skin conditions, with emphasis on Hidradenitis Suppurativa. Trials are evaluating new biological therapies like lutikizumab for moderate to severe cases.

  • Inflammatory Skin Diseases
  • Novel Biological Treatments
  • Chronic Condition Management

Research focuses on improving symptoms and quality of life for patients with persistent skin disorders.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.